The Use of the Point of Care Helena ICHOR/Plateletworks® and the Accumetrics Ultegra® RPFA for Assessment of Platelet Function with GPIIb-IIIa Antagonists Melanie M. WhiteRajini KrishnanLisa K. Jennings OriginalPaper Pages: 163 - 169
Antibodies to Platelet Factor 4/Heparin are Associated with Elevated Endothelial Cell Activation Markers in Patients with Acute Coronary Ischemic Syndromes Mary Ann MascelliEfthymios N. DeliargyrisDavid C. Sane OriginalPaper Pages: 171 - 175
Losartan and Simvastatin Inhibit Platelet Activation in Hypertensive Patients Shosaku NomuraAkira ShouzuToshiji Iwasaka OriginalPaper Pages: 177 - 185
Bleeding Complications After Contemporary Pharmacoinvasive Therapy for ST Elevation Myocardial Infarction Matthew J. GutierrezAtul AggarwalHarold L. Dauerman OriginalPaper Pages: 187 - 192
Vascular Endothelial Tissue Factor Pathway Inhibitor Kinetics in Culture Following Exposure to DX-9065a—A Selective and Direct Factor Xa Inhibitor Richard C. BeckerJohn H. AlexanderRobert A. Harrington OriginalPaper Pages: 193 - 197
Perioperative Anticoagulation for Patients with Mechanical Heart Valves: A Survey of Current Practice David A. GarciaWalter AgenoMark A. Crowther OriginalPaper Pages: 199 - 203
Budd-Chiari Syndrome Associated with Visceral Leishmaniasis and Factor V Leiden Mutation Emel GürkanÇağatay ÜnsalDidem Arslan OriginalPaper Pages: 205 - 207
Pregnancies and Oral Contraceptive Therapy in Severe (Homozygons) FXII Deficiency: A Study in 12 Patients and Review of the Literature A. GirolamiN. ZoccaF. Fabris OriginalPaper Pages: 209 - 212
Partial Splenic Embolization in Myelodysplastic Syndrome Associated with Immune Thrombocytopenia Hakan OzdoguCan BogaEbru Kı zı lkı lı c OriginalPaper Pages: 213 - 216